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Objectives The purpose of this research was to evaluate the relationship between coronary and carotid atherosclerotic dis-
ease using current guidelines for the definition of carotid artery stenosis (CAS).
Background The reported prevalence of concomitant coronary and carotid atherosclerotic disease has varied among studies
due to differences in study populations and methodologies used.
Methods We performed a retrospective analysis of prospectively collected data obtained between January 2007 and May
2009 from consecutive patients undergoing same-day coronary angiography and carotid Doppler studies. Spear-
man correlations and multinomial logistic regression models were used to identify independent correlates of CAS.
Results The study included 1,405 patients (age 65  11 years, 77.2% male), of whom 12.8% had significant CAS (peak
systolic velocity [PSV] 125 cm/s) and 4.6% had severe CAS (PSV 230 cm/s). Mild CAS (PSV 125 cm/s and
the presence of a sonographic atherosclerotic lesion) was present in 58%. The severity of CAS and the extent of
coronary artery disease (CAD) were significantly correlated (r  0.255, p  0.001). Independent predictors of
severe CAS defined by PSV were the presence of left-main or 3-vessel CAD, increasing age, a history of stroke,
smoking status, and diabetes mellitus.
Conclusions The degree of internal carotid artery (ICA) stenosis is related to the extent of CAD, though the prevalence of clini-
cally significant ICA stenosis is lower in specific CAD subsets than previously reported. (J Am Coll Cardiol
2011;57:779–83) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.09.047Atherosclerosis is a systemic inflammatory vascular disorder,
involving multiple arterial beds (1). Although modern
pharmacotherapy and revascularization have markedly en-
hanced the prognosis of patients with atherosclerotic vas-
cular disease, myocardial infarction (MI) and stroke remain
leading causes of mortality and morbidity due to this disease
(2). Concomitant atherosclerotic lesions of the extracranial
internal carotid arteries (ICA) and the coronary circulation
portend an adverse prognosis in various clinical settings,
including asymptomatic individuals, stroke patients, and
patients undergoing coronary artery bypass surgery (3–5).
Previous postmortem (6,7) and clinical (8–11) studies, often
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accepted September 21, 2010.small in sample size, have reported a variable prevalence of
concomitant carotid and coronary lesions in patients with or
without clinically evident cardiovascular disease. Thus, the
prevalence of clinically important, concomitant carotid ar-
tery stenosis (CAS) and coronary artery disease (CAD)
requires further definition in larger populations.
We performed ICA duplex ultrasound studies in consec-
utive patients undergoing clinically driven nonemergent
coronary artery angiography. The prevalence and predic-
tors of severe internal CAS in patients with CAD were
analyzed using current consensus guidelines for the def-
inition of CAS (12).
Methods
Study population. Consecutive hospitalized and ambula-
tory patients undergoing nonemergent coronary angiogra-
phy between January 2007 and May 2009 were enrolled in
the Tel-Aviv Prospective Angiography Study, as previously
described (13). Of these, 1,490 patients underwent a carotid
ultrasound and Doppler study within 24 h of the coronary
procedure. Eighty-five individuals were excluded from the
present analyses due to missing data.
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Concomitant Carotid and Coronary Disease February 15, 2011:779–83Definitions of CAS. Athero-
sclerosis of both the left and right
ICA was assessed by a sonogra-
phy technician who was blinded
to clinical and coronary angio-
graphic data. The ICA were
scanned with carotid duplex
equipment (HD11 XE, Philips
Healthcare, Andover, Massachu-
setts) with a 3- to 12-MHz lin-
ear array transducer, using a pre-
viously described protocol (14).
ICA atherosclerosis was evalu-
ated by the maximum percentage
of diameter reduction recorded
by B-mode ultrasound, and by
the peak systolic velocity (PSV)
and peak diastolic velocity per
Doppler. Lesion severity was defined as the greatest stenosis
observed either on the right or left ICA. Ultrasound and
Doppler findings were classified into 1 of the following 5
categories (12): normal (PSV 125 cm/s with no signs of
atherosclerotic lesions); mild CAS (defined as PSV 125
cm/s and the presence of a sonographic atherosclerotic
lesion correlating to diameter stenosis of 50%); moderate
CAS (defined as PSV between 125 and 230 cm/s correlating
to diameter stenosis of 50% to 70%); severe CAS (defined as
PSV 230 cm/s correlating to diameter stenosis of 70%);
and total or near occlusion (defined as 0 PSV and no visible
Demographic and ClinicalCharacteristics of the Study PopulationTable 1 Demographic and ClinicalCharacteristics of the Study Population
Medical history
Age, yrs 65 11
Male 1,084 (77.2)
Current smoker 211 (15.0)
Past smoker 218 (15.5)
Diabetes mellitus 536 (38.1)
Hypertension 732 (52.1)
Dyslipidemia 1,039 (74.0)
Post-MI 333 (23.7)
Post-stroke 50 (3.6)
Post-CABG 206 (14.7)
CRF 92 (6.5)
Renal dialysis 7 (0.5)
Indications for coronary angiography
Nonspecific chest pain evaluation 63 (4.4)
Stable angina pectoris 184 (13.0)
Unstable angina 559 (39.7)
Acute MI 52 (3.7)
Positive stress test 214 (15.2)
Pre-valve surgery 66 (4.6)
Staged angioplasty 188 (13.3)
Other 79 (5.6)
Values are mean  SD or n (%).
Abbreviations
and Acronyms
CABG  coronary artery
bypass grafting
CAD  coronary artery
disease
CAS  carotid artery
stenosis
ICA  internal carotid
artery
LMD  left main coronary
artery disease
MI  myocardial infarction
PSV  peak systolic
velocity
VD  vessel diseases
CABG coronary artery bypass grafting; CRF chronic renal failure; MImyocardial infarction;
PCI  primary coronary intervention.flow). Evidence of clinically significant ICA disease was
defined as PSV 125 cm/s.
Definitions of CAD. Coronary angiography was per-
formed by standard techniques. The severity of coronary
lesions was determined by visual estimation or by a quan-
titative coronary angiography program (Xcelera, Philips
Healthcare) at the discretion of the interventional cardiol-
ogist performing the procedure. Clinically significant CAD
was defined as the presence of a coronary lesion resulting in
a lumen diameter stenosis70% in a major epicardial artery
(left anterior descending artery, left circumflex artery, right
coronary artery) or one of its major branches (15). Clinically
significant left main disease was defined as a lumen diameter
stenosis 50% (15). Patients were stratified according to
the number of involved vessels as follows: normal coronaries
or nonobstructive CAD (individuals not meeting the criteria
for clinically significant CAD), 1VD, 2VD, 3VD (signifi-
cant lesions in 1, 2, and 3 vessels, respectively), and LMD
(significant disease of the left main coronary artery, with or
without concomitant lesions in other vessels) (15).
Statistical analysis. Continuous variables are presented as
mean  SD. Spearman correlation was used to evaluate the
relation between CAS severity and CAD extent. Multino-
mial logistic regression models were fitted for CAS severity,
defined by either PSV or end-diastolic volume as the
dependent variable, with adjustment for CAD extent, age,
sex, smoking status, hypertension, diabetes mellitus, hyper-
lipidemia, chronic renal failure, history of MI, history of
coronary artery bypass graft surgery (CABG), stroke, or
transient ischemic attack. For all analyses, a 2-tailed p 
.05 was considered statistically significant. The SPSS
tatistical package (SPSS Inc., Chicago, Illinois) was used.
esults
he final study population consisted of 1,405 patients.
heir demographic and clinical features are presented in
able 1. The prevalence of the various categories of CAS
Frequencies of CAS Severity by the Degree ofCAD SeverityTable 2 Frequencies of CAS S verity by the Degree ofCAD Severity
CAD Extent
CAS Severity
Normal or
Mild Moderate
Severe or
Total
Occlusion
Normal or nonobstructive 272 (94.1) 11 (3.8) 6 (2.1)
1-vessel disease 243 (93.5) 9 (3.5) 8 (3.1)
2-vessel disease 335 (87) 36 (9.4) 14 (3.6)
3-vessel disease 319 (82.2) 42 (10.8) 27 (7.0)
Left main disease 57 (68.7) 17 (20.5) 9 (10.8)
Values are n (%). Carotid artery stenosis (CAS) defined as: normal (PSV 125 cm/s with no signs
of atherosclerotic lesions); mild CAS (defined as PSV 125 cm/s and the presence of a
sonographic atherosclerotic lesion correlating to diameter stenosis of 50%); moderate CAS
(defined as PSV between 125 and 230 cm/s correlating to diameter stenosis of 50% to 70%);
severe CAS (defined as PSV 230 cm/s correlating to diameter stenosis of 70%); and total or
ear occlusion (defined as 0 PSV and no visible flow).
CAD  coronary artery disease.everity and the CAD extent are presented in Table 2. In
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February 15, 2011:779–83 Concomitant Carotid and Coronary Diseasethe entire study population, 42% had patent carotid arteries
without any evidence of atherosclerotic plaque, whereas the
prevalence of moderate and severe CAS was 12.8% and
4.6%, respectively. The severity of CAS and CAD extent
were directly correlated (r  0.255, p  0.001). Clinically
significant CAS (50%) was found in 5.9%, 6.6%, 13%,
17.8%, and 31.3% among patients with normal or nonob-
structive CAD, 1VD, 2VD, 3VD, and LMD, respectively.
Severe CAS (70%) was found in 2.1%, 3.1%, 3.6%, 7%,
and 10.8% of patients with normal or nonobstructive CAD,
1VD, 2VD, 3VD, and LMD, respectively.
The logistic regression modeling results are presented in
Table 3. Independent predictors of severe CAS or total
internal carotid occlusion were the presence of LMD or
3VD, increasing age, a history of stroke, smoking status,
diabetes mellitus. A similar analysis using end-diastolic
volume did not yield statistically significant results (data not
shown).
Discussion
The present study represents the largest analysis to date of
the prevalence of concomitant coronary and carotid athero-
sclerotic arterial disease. The principal finding of this
analysis is that the presence of ICA stenosis is directly
related to the extent of CAD, though the prevalence of
moderate and severe CAS in patients with CAD is lower
than previously reported.
Clinical importance of concomitant CAD and CAS.
Concurrent CAD and CAS is frequently detected in clinical
practice and has important prognostic implications in symp-
tomatic patients who are considered for revascularization of
one or both of these vascular beds as well as in entirely
Multivariate Correlates of Doppler-Defined CASTable 3 Multivariate Correlates of Doppler-Defined CAS
Variable
Mild CAS
OR (95% CI) p Value
Normal or nonobstructive CAD 1.00 (reference)
1-vessel CAD 1.86 (1.26–2.74) 0.002
2-vessel CAD 2.26 (1.56–3.29) <0.001
3-vessel CAD 2.49 (1.68–3.68) <0.001
Left main CAD 2.47 (1.27–4.79) 0.008
History of smoking 1.68 (1.27–2.23) <0.001
Age (for each 10-yr increase) 1.98 (1.74–2.26) <0.001
Male 0.80 (0.58–1.09) 0.160
Hypertension 1.14 (0.88–1.47) 0.328
Diabetes mellitus 1.31 (1.01–1.68) 0.041
Hyperlipidemia 0.94 (0.71–1.25) 0.670
Post-MI 0.94 (0.70–1.27) 0.689
Post-stroke 1.44 (0.68–3.04) 0.343
Post-CABG 1.36 (0.91–2.04) 0.131
CRF 1.15 (0.66–2.02) 0.621
Bold values indicate statistical significance. Multinomial logistic regression model for CAS sever
Carotid artery stenosis defined as: normal (PSV 125 cm/s with no signs of atherosclerotic le
orrelating to diameter stenosis of50%): moderate CAS (defined as PSV between 125 and 230 c
o diameter stenosis of 70%); and total or near occlusion (defined as 0 PSV and no visible flow).
CI  confidence interval; OR  odds ratio; other abbreviations as in Tables 1 and 2.asymptomatic individuals. In patients with traditional athero-
sclerotic risk factors but not necessarily a prior cardiovascular
event, the mere presence of a carotid bruit predicts increased
risk of MI and cardiac death (4). In fact, progression of CAS
on sequential Doppler studies has been shown to be a stronger
correlate of future MI events than of stroke (16). The presence
of CAS has been shown in multiple (17), though not in all
(18), studies to increase the risk of perioperative stroke in
patients undergoing CABG. Conversely, the presence of CAD
increases the risk of peripheral vascular surgery including
carotid endarterectomy (19). Notwithstanding, the role of
pre-emptive interventions on asymptomatic carotid or coro-
nary lesions prior to coronary or carotid revascularization,
respectively, is controversial (18,20), and guideline recommen-
dations regarding screening for asymptomatic CAS in patients
with CAD are unsettled (21,22). Our data indicate that
although at least some degree of atherosclerotic carotid disease
is frequently detected among patients with extensive CAD
(i.e., 3VD and/or LMD), the prevalence of CAS potentially
mandating intervention is lower than previously reported (i.e.,
in the range of 7% to 11% in the highest-risk anatomic subsets
of CAD).
Previous studies. The reported prevalence of asymptomatic
CAS has ranged from 2% to 18% among screened populations,
although in high-risk individuals, including those with coro-
nary artery disease, the prevalence of significant CAS has been
reported to be as high as 30% (21). In a small study (n 223),
a CAS 50% was found in 5%, 13%, 25%, and 40% of
patients with 1VD, 2VD, 3VD, and LMD, respectively (9). In
separate study in 632 Japanese patients, the prevalence of
AS 50% was 14%, 21%, and 36%, in patients with 1VD,
VD, and 3VD, respectively (8). These rates of CAS are
Moderate CAS Severe CAS or Total Occlusion
OR (95% CI) p Value OR (95% CI) p Value
.00 (reference) 1.00 (reference)
.26 (0.49–3.25) 0.639 1.85 (0.60–5.71) 0.283
.92 (1.81–8.46) 0.001 2.50 (0.88–7.13) 0.087
.91 (1.79–8.57) 0.001 4.20 (1.53–11.52) 0.005
.77 (3.18–24.16) <0.001 7.20 (2.00–25.95) 0.003
.88 (1.14–3.11) 0.013 3.25 (1.80–5.85) <0.001
.77 (2.17–3.53) <0.001 2.42 (1.79–3.26) <0.001
.65 (0.38–1.11) 0.116 0.57 (0.29–1.09) 0.088
.31 (0.82–2.08) 0.261 1.23 (0.68–2.21) 0.490
.58 (1.02–2.47) 0.042 1.83 (1.05–3.19) 0.034
.94 (0.55–1.61) 0.829 1.21 (0.57–2.57) 0.613
.22 (0.75–2.01) 0.423 1.53 (0.84–2.78) 0.165
.59 (0.94–7.16) 0.066 4.71 (1.69–13.15) 0.003
.59 (0.87–2.87) 0.129 1.99 (0.99–4.02) 0.055
.77 (1.36–5.61) 0.005 1.81 (0.72–4.54) 0.205
e dependant variable. The CAS severity variables are referenced to the presence of normal CAS.
ild CAS (defined as PSV 125 cm/s and the presence of a sonographic atherosclerotic lesion
rrelating to diameter stenosis of 50% to 70%): severe CAS (defined as PSV230 cm/s correlating1
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Concomitant Carotid and Coronary Disease February 15, 2011:779–83higher than found in our patients, a difference most prominent
(1.5- to 2-fold) among patients with 3VD and LMD.
everal explanations might account for the difference between
ur findings and those reported by others. First, the definition
f “significant” CAS has differed across studies. Whereas other
uthors have used a definition of 50%, our study analyzed
tenoses exceeding both 50% and 70% diameter stenosis. It
hould be noted the 70% definition for severe CAS conforms
o current guidelines (12) and is clinically relevant for decisions
egarding revascularization therapy. Second, studies have dif-
ered in their sample sizes as well as the methodology em-
loyed. Kallikazaros et al. (9) defined diameter stenosis using
-mode ultrasonography in mild CAS, whereas Doppler flow
elocities were used for severe CAS. In contrast, in the present
tudy, we used flow velocity for all lesions (12,23). Third, the
animoto study was limited to Japanese patients (8), whereas
ur study was conducted in an ethnically diverse population.
inally, our study was conducted several years after the afore-
entioned studies. It is possible that better adherence to
ptimal medical therapy for cardiovascular disease accounts in
art for the decreasing prevalence of severe CAS among
atients with symptomatic CAD (24).
tudy limitations. The patients included in this study were
eferred for nonemergent coronary angiography for suspected
AD. Therefore, the prevalence of concomitant carotid and
oronary disease in asymptomatic individuals could not be
valuated. Additionally, the study provides no information on
he prevalence of clinically-important coronary artery disease
mong patients with acutely symptomatic carotid artery le-
ions. Lastly, due to the small numbers of moderate and severe
AS, the multinomial logistic regression model may be over-
tted, and cross-validation is needed.
ummary and clinical implications. This analysis con-
rms the findings of previous studies that have reported a
irect relation between the extent of CAD and the presence
f CAS among patients referred for coronary angiography,
hough the prevalence of clinically significant CAS in these
atients appears to be lower than previously reported.
Our findings support current guidelines that do not
ndorse nonselective screening for CAS among individuals
ithout symptoms attributable to the carotid circulation,
ncluding those with CAD (21). This study also lends further
redence to the recommendation to screen high-risk individ-
als with CAD (including those with multivessel disease or
MD, a history of stroke, advanced age, and smokers) (21). Of
ote, percutaneous intervention is increasingly utilized in
AD subsets previously treated almost exclusively by CABG
e.g., LMD) (25). Guideline recommendations on screening
or CAS prior to CABG should probably be extended to this
ncreasing population of patients (21).
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